Larvol Delta - CARDEAPlus-A-PlaceboControlled-Study-of-Auxora-for-the-Extended-Treatment-of-High-Risk-Patients-With-Critical-COVID19-Pneumonia

Auxora (CM4620) - CalciMedica

http://clinicaltrials.gov/ct2/show/NCT05171920

Mar 31, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next